444 related articles for article (PubMed ID: 21269314)
1. Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180.
Choi Y; Lee SE; Fukuda S; Hashimoto T; Kim SC
J Dermatol; 2011 Feb; 38(2):169-72. PubMed ID: 21269314
[TBL] [Abstract][Full Text] [Related]
2. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
[TBL] [Abstract][Full Text] [Related]
3. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
[TBL] [Abstract][Full Text] [Related]
4. Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230.
Leverkus M; Bhol K; Hirako Y; Pas H; Sitaru C; Baier G; Bröcker EB; Jonkman MF; Ahmed AR; Zillikens D
Br J Dermatol; 2001 Dec; 145(6):998-1004. PubMed ID: 11899157
[TBL] [Abstract][Full Text] [Related]
5. Mucous membrane pemphigoid with generalized blisters: IgA and IgG autoantibodies target both laminin-332 and type XVII collagen.
Hayashi I; Shinkuma S; Shimizu S; Natsuga K; Ujiie H; Yasui C; Tsuchiya K; Nishie W; Shimizu H
Br J Dermatol; 2012 May; 166(5):1116-20. PubMed ID: 22182184
[TBL] [Abstract][Full Text] [Related]
6. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
[TBL] [Abstract][Full Text] [Related]
7. IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis.
Christophoridis S; Büdinger L; Borradori L; Hunziker T; Merk HF; Hertl M
Br J Dermatol; 2000 Aug; 143(2):349-55. PubMed ID: 10951144
[TBL] [Abstract][Full Text] [Related]
8. Acute blistering disease presenting IgG autoantibodies against NC16A and COOH-terminal domains of BP180 and laminin-332, with characteristic distribution of eruptions.
Kurashige Y; Minemura T; Nagatani T; Koga H; Hashimoto T
Eur J Dermatol; 2013; 23(1):109-10. PubMed ID: 23306276
[No Abstract] [Full Text] [Related]
9. Case of pemphigoid involving skin and mucous membrane with immunoglobulin G autoantibodies targeted to BP180 and laminin-332.
Hosoda S; Suzuki M; Komine M; Fujita E; Yamada T; Murata S; Koga H; Hashimoto T; Ohtsuki M
J Dermatol; 2013 Dec; 40(12):1067-8. PubMed ID: 24330181
[No Abstract] [Full Text] [Related]
10. Mucous membrane pemphigoid with IgG autoantibodies to the 120-kDa ectodomain of type XVII collagen (BP180/linear IgA dermatosis antigen) in a patient with idiopathic thrombocytopenic purpura.
Hirakawa Y; Oiso N; Ishii N; Koga H; Tatebayashi M; Uchida S; Matsuda H; Hashimoto T; Kawada A
Acta Derm Venereol; 2015 Apr; 95(4):493-4. PubMed ID: 25178495
[No Abstract] [Full Text] [Related]
11. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
13. Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain.
Hofmann S; Thoma-Uszynski S; Hunziker T; Bernard P; Koebnick C; Stauber A; Schuler G; Borradori L; Hertl M
J Invest Dermatol; 2002 Nov; 119(5):1065-73. PubMed ID: 12445194
[TBL] [Abstract][Full Text] [Related]
14. IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis.
Horváth B; Niedermeier A; Podstawa E; Müller R; Hunzelmann N; Kárpáti S; Hertl M
Exp Dermatol; 2010 Jul; 19(7):648-53. PubMed ID: 20500772
[TBL] [Abstract][Full Text] [Related]
15. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180.
Schmidt E; Skrobek C; Kromminga A; Hashimoto T; Messer G; Bröcker EB; Yancey KB; Zillikens D
Br J Dermatol; 2001 Nov; 145(5):778-83. PubMed ID: 11736901
[TBL] [Abstract][Full Text] [Related]
16. IgE autoantibodies against the intracellular domain of BP180.
Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
[TBL] [Abstract][Full Text] [Related]
17. Pure ocular mucous membrane pemphigoid reactive with both β4 integrin and the BP180 C-terminal domain.
Solano-López G; Concha-Garzón MJ; Sánchez-Pérez J; Hirako Y; Li X; Ishii N; Hashimoto T; Daudén E
Br J Dermatol; 2015 Feb; 172(2):542-4. PubMed ID: 25059542
[No Abstract] [Full Text] [Related]
18. Integrin β4 is a major target antigen in pure ocular mucous membrane pemphigoid.
Li X; Qian H; Sogame R; Hirako Y; Tsuruta D; Ishii N; Koga H; Tsuchisaka A; Jin Z; Tsubota K; Fukumoto A; Sotozono C; Kinoshita S; Hashimoto T
Eur J Dermatol; 2016 Jun; 26(3):247-53. PubMed ID: 27193492
[TBL] [Abstract][Full Text] [Related]
19. The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis.
Roh JY; Yee C; Lazarova Z; Hall RP; Yancey KB
Br J Dermatol; 2000 Jul; 143(1):104-11. PubMed ID: 10886143
[TBL] [Abstract][Full Text] [Related]
20. Oral pemphigoid autoantibodies preferentially target BP180 ectodomain.
Calabresi V; Carrozzo M; Cozzani E; Arduino P; Bertolusso G; Tirone F; Parodi A; Zambruno G; Di Zenzo G
Clin Immunol; 2007 Feb; 122(2):207-13. PubMed ID: 17141573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]